Elk River Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.85M | Sell |
9,497
-241
| -2% | -$97.8K | 0.66% | 41 |
|
|
2025
Q1 | $4.85M | Sell |
9,738
-121
| -1% | -$60.3K | 0.91% | 34 |
|
|
2024
Q4 | $5.13M | Sell |
9,859
-38
| -0.4% | -$19.8K | 0.93% | 32 |
|
|
2024
Q3 | $6.13M | Buy |
9,897
+100
| +1% | +$61.9K | 1.11% | 29 |
|
|
2024
Q2 | $5.42M | Buy |
9,797
+71
| +0.7% | +$39.3K | 1.06% | 32 |
|
|
2024
Q1 | $5.66M | Sell |
9,726
-1,036
| -10% | -$603K | 1.15% | 28 |
|
|
2023
Q4 | $5.72M | Buy |
10,762
+71
| +0.7% | +$37.7K | 1.1% | 29 |
|
|
2023
Q3 | $5.42M | Buy |
10,691
+95
| +0.9% | +$48.1K | 1.2% | 28 |
|
|
2023
Q2 | $5.53M | Sell |
10,596
-127
| -1% | -$66.3K | 1.18% | 28 |
|
|
2023
Q1 | $6.18M | Buy |
10,723
+315
| +3% | +$182K | 1.4% | 25 |
|
|
2022
Q4 | $5.73M | Buy |
10,408
+50
| +0.5% | +$27.6K | 1.39% | 25 |
|
|
2022
Q3 | $5.26M | Buy |
10,358
+329
| +3% | +$167K | 1.39% | 24 |
|
|
2022
Q2 | $5.45M | Buy |
10,029
+163
| +2% | +$88.6K | 1.38% | 23 |
|
|
2022
Q1 | $5.83M | Buy |
9,866
+618
| +7% | +$365K | 1.27% | 23 |
|
|
2021
Q4 | $6.17M | Buy |
9,248
+85
| +0.9% | +$56.7K | 1.4% | 22 |
|
|
2021
Q3 | $5.24M | Buy |
9,163
+222
| +2% | +$127K | 1.32% | 24 |
|
|
2021
Q2 | $4.51M | Buy |
8,941
+161
| +2% | +$81.3K | 1.17% | 29 |
|
|
2021
Q1 | $4.01M | Buy |
8,780
+819
| +10% | +$374K | 1.14% | 29 |
|
|
2020
Q4 | $3.71M | Buy |
+7,961
| New | +$3.71M | 1.23% | 29 |
|